{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:09:17Z","timestamp":1789517357187,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11102-024-01482-0","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T13:15:00Z","timestamp":1735305300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Can we predict the risk of venous thromboembolism in patients with Cushing\u2019s syndrome: a nationwide cohort analysis"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3220-6321","authenticated-orcid":false,"given":"Yaron","family":"Rudman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Michaelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9188-3894","authenticated-orcid":false,"given":"Ilan","family":"Shimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0551-4759","authenticated-orcid":false,"given":"Idit","family":"Dotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7576-8327","authenticated-orcid":false,"given":"Tzippy","family":"Shochat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2359-5249","authenticated-orcid":false,"given":"Shiri","family":"Kushnir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-6289","authenticated-orcid":false,"given":"Maria","family":"Fleseriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9376-344X","authenticated-orcid":false,"given":"Amit","family":"Akirov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"issue":"2","key":"1482_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1001\/jama.2023.11305","volume":"330","author":"M Reincke","year":"2023","unstructured":"Reincke M, Fleseriu M (2023) Cushing syndrome: a review. JAMA 330(2):170\u2013181. https:\/\/doi.org\/10.1001\/jama.2023.11305","journal-title":"JAMA"},{"issue":"10418","key":"1482_CR2","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/S0140-6736(23)01961-X","volume":"402","author":"M Gadelha","year":"2023","unstructured":"Gadelha M, Gatto F, Wildemberg LE, Fleseriu M (2023) Cushing\u2019s syndrome. Lancet (London, England) 402(10418):2237\u20132252. https:\/\/doi.org\/10.1016\/S0140-6736(23)01961-X","journal-title":"Lancet (London, England)"},{"issue":"12","key":"1482_CR3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR, Boguszewski CL, Bronstein MD, Buchfelder M, Carmichael JD, Casanueva FF, Castinetti F, Chanson P, Findling J, Gadelha M, Geer EB, Giustina A, Grossman A, Gurnell M, Ho K, Biller BMK (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabet Endocrinol 9(12):847\u2013875. https:\/\/doi.org\/10.1016\/S2213-8587(21)00235-7","journal-title":"Lancet Diabet Endocrinol"},{"issue":"6","key":"1482_CR4","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1210\/jc.2012-3582","volume":"98","author":"OM Dekkers","year":"2013","unstructured":"Dekkers OM, Horv\u00e1th-Puh\u00f3 E, J\u00f8rgensen JO, Cannegieter SC, Ehrenstein V, Vandenbroucke JP, Pereira AM, S\u00f8rensen HT (2013) Multisystem morbidity and mortality in Cushing\u2019s syndrome: a cohort study. J Clin Endocrinol Metab 98(6):2277\u20132284. https:\/\/doi.org\/10.1210\/jc.2012-3582","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1482_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","volume":"4","author":"R Pivonello","year":"2016","unstructured":"Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A (2016) Complications of Cushing\u2019s syndrome: state of the art. Lancet Diabet Endocrinol 4(7):611\u2013629. https:\/\/doi.org\/10.1016\/S2213-8587(16)00086-3","journal-title":"Lancet Diabet Endocrinol"},{"issue":"5","key":"1482_CR6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/0002-9343(52)90027-2","volume":"13","author":"CM Plotz","year":"1952","unstructured":"Plotz CM, Knowlton AI, Ragan C (1952) The natural history of Cushing\u2019s syndrome. Am J Med 13(5):597\u2013614. https:\/\/doi.org\/10.1016\/0002-9343(52)90027-2","journal-title":"Am J Med"},{"issue":"8","key":"1482_CR7","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1210\/clinem\/dgac265","volume":"107","author":"P Limumpornpetch","year":"2022","unstructured":"Limumpornpetch P, Morgan AW, Tiganescu A, Baxter PD, Nyawira Nyaga V, Pujades-Rodriguez M, Stewart PM (2022) The effect of endogenous Cushing syndrome on all-cause and cause-specific mortality. J Clin Endocrinol Metab 107(8):2377\u20132388. https:\/\/doi.org\/10.1210\/clinem\/dgac265","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1482_CR8","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.3390\/ijms24043169","volume":"24","author":"D Pastori","year":"2023","unstructured":"Pastori D, Cormaci VM, Marucci S, Franchino G, Del Sole F, Capozza A, Fallarino A, Corso C, Valeriani E, Menichelli D, Pignatelli P (2023) A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology. Int J Mol Sci 24(4):3169. https:\/\/doi.org\/10.3390\/ijms24043169","journal-title":"Int J Mol Sci"},{"issue":"9","key":"1482_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1001\/jamainternmed.2013.122","volume":"173","author":"SA Johannesdottir","year":"2013","unstructured":"Johannesdottir SA, Horv\u00e1th-Puh\u00f3 E, Dekkers OM, Cannegieter SC, J\u00f8rgensen JO, Ehrenstein V, Vandenbroucke JP, Pedersen L, S\u00f8rensen HT (2013) Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med 173(9):743\u2013752. https:\/\/doi.org\/10.1001\/jamainternmed.2013.122","journal-title":"JAMA Intern Med"},{"issue":"11","key":"1482_CR10","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","volume":"8","author":"S Barbar","year":"2010","unstructured":"Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, De Bon E, Tormene D, Pagnan A, Prandoni P (2010) A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost: JTH 8(11):2450\u20132457. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.04044.x","journal-title":"J Thromb Haemost: JTH"},{"issue":"1","key":"1482_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/ejendo\/lvad176","volume":"190","author":"K Isand","year":"2024","unstructured":"Isand K, Feelders R, Brue T, Toth M, Deutschbein T, Reincke M, Kr\u0161ek M, Santos A, Demtr\u00f6der F, Chabre O, Strasburger CJ, Aulinas Maso A, Volke V, Pereira AM, Lohmann R, Gich Saladich I, Ercusyn Study Group, Webb SM, Wass J, Valassi E (2024) High prevalence of venous thrombotic events in Cushing\u2019s syndrome: data from ERCUSYN and details in relation to surgery. Eur J Endocrinol 190(1):75\u201385. https:\/\/doi.org\/10.1093\/ejendo\/lvad176","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1482_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13023-022-02320-x","volume":"17","author":"FM van Haalen","year":"2022","unstructured":"van Haalen FM, Kaya M, Pelsma ICM, Dekkers OM, Biermasz NR, Cannegieter SC, Huisman MV, van Vlijmen BJM, Feelders RA, Klok FA, Pereira AM, Cushing EERN, Endo-ERN Cushing and Thrombosis Study Group (2022) Current clinical practice for thromboprophylaxis management in patients with Cushing\u2019s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN). Orphanet J Rare Dis 17(1):178. https:\/\/doi.org\/10.1186\/s13023-022-02320-x","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"1482_CR13","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1210\/jc.2011-1661","volume":"96","author":"DJ Stuijver","year":"2011","unstructured":"Stuijver DJ, van Zaane B, Feelders RA, Debeij J, Cannegieter SC, Hermus AR, van den Berg G, Pereira AM, de Herder WW, Wagenmakers MA, Kerstens MN, Zelissen PM, Fliers E, Schaper N, Drent ML, Dekkers OM, Gerdes VE (2011) Incidence of venous thromboembolism in patients with Cushing\u2019s syndrome: a multicenter cohort study. J Clin Endocrinol Metab 96(11):3525\u20133532. https:\/\/doi.org\/10.1210\/jc.2011-1661","journal-title":"J Clin Endocrinol Metab"},{"key":"1482_CR14","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3389\/fendo.2018.00805","volume":"9","author":"J Wagner","year":"2019","unstructured":"Wagner J, Langlois F, Lim DST, McCartney S, Fleseriu M (2019) Hypercoagulability and risk of venous thromboembolic events in endogenous Cushing\u2019s syndrome: a systematic meta-analysis. Front Endocrinol 9:805. https:\/\/doi.org\/10.3389\/fendo.2018.00805","journal-title":"Front Endocrinol"},{"issue":"2","key":"1482_CR15","doi-asserted-by":"publisher","first-page":"033","DOI":"10.1210\/jendso\/bvz033","volume":"4","author":"MG Suarez","year":"2019","unstructured":"Suarez MG, Stack M, Hinojosa-Amaya JM, Mitchell MD, Varlamov EV, Yedinak CG, Cetas JS, Sheppard B, Fleseriu M (2019) Hypercoagulability in Cushing syndrome, prevalence of thrombotic events: a large, single-center, retrospective study. J Endocr Soc 4(2):033. https:\/\/doi.org\/10.1210\/jendso\/bvz033","journal-title":"J Endocr Soc"},{"issue":"2","key":"1482_CR16","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1210\/js.2018-00278","volume":"3","author":"B Babic","year":"2018","unstructured":"Babic B, De Roulet A, Volpe A, Nilubol N (2018) Is VTE prophylaxis necessary on discharge for patients undergoing adrenalectomy for cushing syndrome? J Endocr Soc 3(2):304\u2013313. https:\/\/doi.org\/10.1210\/js.2018-00278","journal-title":"J Endocr Soc"},{"issue":"2","key":"1482_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/ejendo\/lvae098","volume":"191","author":"Y Rudman","year":"2024","unstructured":"Rudman Y, Fleseriu M, Dery L, Masri-Iraqi H, Sasson L, Shochat T, Kushnir S, Shimon I, Akirov A (2024) Endogenous Cushing\u2019s syndrome and cancer risk. Eur J Endocrinol 191(2):223\u2013231. https:\/\/doi.org\/10.1093\/ejendo\/lvae098","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1482_CR18","doi-asserted-by":"publisher","first-page":"e901","DOI":"10.1210\/clinem\/dgad453","volume":"109","author":"S Puglisi","year":"2024","unstructured":"Puglisi S, Perini AME, Botto C, Oliva F, Terzolo M (2024) Long-term consequences of Cushing syndrome: a systematic literature review. J Clin Endocrinol Metab 109(3):e901\u2013e919. https:\/\/doi.org\/10.1210\/clinem\/dgad453","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1482_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/cen.12094","volume":"78","author":"R van der Pas","year":"2013","unstructured":"van der Pas R, Leebeek FW, Hofland LJ, de Herder WW, Feelders RA (2013) Hypercoagulability in Cushing\u2019s syndrome: prevalence, pathogenesis and treatment. Clin Endocrinol 78(4):481\u2013488. https:\/\/doi.org\/10.1111\/cen.12094","journal-title":"Clin Endocrinol"},{"issue":"4","key":"1482_CR20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/ejendo\/lvad041","volume":"188","author":"F Vogel","year":"2023","unstructured":"Vogel F, Braun L, Zopp S, Nowak E, Schreiner J, Benz I, Rubinstein G, K\u00fcnzel H, Ritzel K, Kroiss M, Honegger J, Beuschlein F, Schilbach K, Teupser D, Bidlingmaier M, Reincke M (2023) Low-grade inflammation during the glucocorticoid withdrawal phase in patients with Cushing\u2019s syndrome. Eur J Endocrinol 188(4):375\u2013384. https:\/\/doi.org\/10.1093\/ejendo\/lvad041","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1482_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1530\/EJE-13-0555","volume":"171","author":"M Terzolo","year":"2014","unstructured":"Terzolo M, Allasino B, Pia A, Peraga G, Daffara F, Laino F, Ardito A, Termine A, Paccotti P, Berchialla P, Migliaretti G, Reimondo G (2014) Surgical remission of Cushing\u2019s syndrome reduces cardiovascular risk. Eur J Endocrinol 171(1):127\u2013136. https:\/\/doi.org\/10.1530\/EJE-13-0555","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"1482_CR22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1055\/s-0043-100113","volume":"49","author":"A Tirosh","year":"2017","unstructured":"Tirosh A, Lodish M, Lyssikatos C, Belyavskaya E, Feelders RA, Stratakis CA (2017) Coagulation profile in patients with different etiologies for Cushing syndrome: a prospective observational study. Horm Metab Res Horm Stoffwechselforschung Horm et Metab 49(5):365\u2013371. https:\/\/doi.org\/10.1055\/s-0043-100113","journal-title":"Horm Metab Res Horm Stoffwechselforschung Horm et Metab"},{"issue":"2","key":"1482_CR23","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s12020-015-0665-z","volume":"52","author":"M Zilio","year":"2016","unstructured":"Zilio M, Mazzai L, Sartori MT, Barbot M, Ceccato F, Daidone V, Casonato A, Saggiorato G, Noventa F, Trementino L, Prandoni P, Boscaro M, Arnaldi G, Scaroni C (2016) A venous thromboembolism risk assessment model for patients with Cushing\u2019s syndrome. Endocrine 52(2):322\u2013332. https:\/\/doi.org\/10.1007\/s12020-015-0665-z","journal-title":"Endocrine"},{"issue":"2","key":"1482_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF03345709","volume":"32","author":"C Erem","year":"2009","unstructured":"Erem C, Nuhoglu I, Yilmaz M, Kocak M, Demirel A, Ucuncu O, Onder Ersoz H (2009) Blood coagulation and fibrinolysis in patients with Cushing\u2019s syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels. J Endocrinol Invest 32(2):169\u2013174. https:\/\/doi.org\/10.1007\/BF03345709","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"1482_CR25","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1530\/EJE-10-0583","volume":"163","author":"L Manetti","year":"2010","unstructured":"Manetti L, Bogazzi F, Giovannetti C, Raffaelli V, Genovesi M, Pellegrini G, Ruocco L, Iannelli A, Martino E (2010) Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing\u2019s syndrome: results from a prospective study before and after surgery. Eur J Endocrinol 163(5):783\u2013791. https:\/\/doi.org\/10.1530\/EJE-10-0583","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"1482_CR26","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s11102-022-01261-9","volume":"25","author":"RA Feelders","year":"2022","unstructured":"Feelders RA, Nieman LK (2022) Hypercoagulability in Cushing\u2019s syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols. Pituitary 25(5):746\u2013749. https:\/\/doi.org\/10.1007\/s11102-022-01261-9","journal-title":"Pituitary"},{"issue":"2","key":"1482_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4183\/aeb.2020.123","volume":"16","author":"G Kora\u0107evi\u0107","year":"2020","unstructured":"Kora\u0107evi\u0107 G, Stojanovi\u0107 M, Petrovi\u0107 S, Simi\u0107 D, Saka\u010d D, Vlajkovi\u0107 M, Stevic M, Koci\u0107 M, \u0110or\u0111evi\u0107 M, Kora\u0107evi\u0107 M (2020) Cushing\u2019s syndrome, a risk factor for venous thromboembolism is a candidate for guidelines. Acta Endocr (Bucharest, Romania\u202f: 2005) 16(2):123\u2013128. https:\/\/doi.org\/10.4183\/aeb.2020.123","journal-title":"Acta Endocr (Bucharest, Romania : 2005)"},{"issue":"3","key":"1482_CR28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1080\/07853890.2016.1252055","volume":"49","author":"R Lupoli","year":"2017","unstructured":"Lupoli R, Ambrosino P, Tortora A, Barba L, Lupoli GA, Di Minno MN (2017) Markers of atherosclerosis in patients with Cushing\u2019s syndrome: a meta-analysis of literature studies. Ann Med 49(3):206\u2013216. https:\/\/doi.org\/10.1080\/07853890.2016.1252055","journal-title":"Ann Med"},{"issue":"2","key":"1482_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3171\/jns.1999.91.2.0175","volume":"91","author":"PL Semple","year":"1999","unstructured":"Semple PL, Laws ER Jr (1999) Complications in a contemporary series of patients who underwent transsphenoidal surgery for Cushing\u2019s disease. J Neurosurg 91(2):175\u2013179. https:\/\/doi.org\/10.3171\/jns.1999.91.2.0175","journal-title":"J Neurosurg"},{"issue":"8","key":"1482_CR30","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1210\/jcem.87.8.8703","volume":"87","author":"M Boscaro","year":"2002","unstructured":"Boscaro M, Sonino N, Scarda A, Barzon L, Fallo F, Sartori MT, Patrassi GM, Girolami A (2002) Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing\u2019s syndrome. J Clin Endocrinol Metab 87(8):3662\u20133666. https:\/\/doi.org\/10.1210\/jcem.87.8.8703","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1482_CR31","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1210\/jc.2012-2893","volume":"98","author":"JK Lambert","year":"2013","unstructured":"Lambert JK, Goldberg L, Fayngold S, Kostadinov J, Post KD, Geer EB (2013) Predictors of mortality and long-term outcomes in treated Cushing\u2019s disease: a study of 346 patients. J Clin Endocrinol Metab 98(3):1022\u20131030. https:\/\/doi.org\/10.1210\/jc.2012-2893","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1482_CR32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1210\/clinem\/dgaa291","volume":"105","author":"E Papakokkinou","year":"2020","unstructured":"Papakokkinou E, Olsson DS, Chantzichristos D, Dahlqvist P, Segerstedt E, Olsson T, Petersson M, Berinder K, Bensing S, H\u00f6ybye C, Ed\u00e9n-Engstr\u00f6m B, Burman P, Bonelli L, Follin C, Petranek D, Erfurth EM, Wahlberg J, Ekman B, \u00c5kerman AK, Schwarcz E, Ragnarsson O (2020) Excess morbidity persists in patients with Cushing\u2019s disease during long-term remission: a Swedish Nationwide study. J Clin Endocrinol Metab 105(8):291. https:\/\/doi.org\/10.1210\/clinem\/dgaa291","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1482_CR33","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11102-023-01343-2","volume":"26","author":"A Mondin","year":"2023","unstructured":"Mondin A, Ceccato F, Voltan G, Mazzeo P, Manara R, Denaro L, Scaroni C, Barbot M (2023) Complications and mortality of Cushing\u2019s disease: report on data collected over a 20-year period at a referral centre. Pituitary 26(5):551\u2013560. https:\/\/doi.org\/10.1007\/s11102-023-01343-2","journal-title":"Pituitary"},{"issue":"1","key":"1482_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/ejendo\/lvae069","volume":"191","author":"S Germann","year":"2024","unstructured":"Germann S, Wimmer R, Laager R, Mueller B, Schuetz P, Kaegi-Braun N, Kutz A (2024) Long-term outcomes in patients with Cushing\u2019s disease vs nonfunctioning pituitary adenoma after pituitary surgery: an active-comparator cohort study. Eur J Endocrinol 191(1):97\u2013105. https:\/\/doi.org\/10.1093\/ejendo\/lvae069","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1482_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1681\/ASN.2007030308","volume":"19","author":"K Wattanakit","year":"2008","unstructured":"Wattanakit K, Cushman M, Stehman-Breen C, Heckbert SR, Folsom AR (2008) Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol 19(1):135\u2013140. https:\/\/doi.org\/10.1681\/ASN.2007030308","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1482_CR36","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/ejendo\/lvad008","volume":"188","author":"V Amodru","year":"2023","unstructured":"Amodru V, Ferriere A, Tabarin A, Castinetti F, Tsagarakis S, Toth M, Feelders RA, Webb SM, Reincke M, Netea-Maier R, Kastelan D, Elenkova A, Maiter D, Ragnarsson O, Santos A, Valassi E, ERCUSYN Study Group (2023) Cushing\u2019s syndrome in the elderly: data from the European Registry on Cushing\u2019s syndrome. Eur J Endocrinol 188(4):395\u2013406. https:\/\/doi.org\/10.1093\/ejendo\/lvad008","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"1482_CR37","doi-asserted-by":"publisher","first-page":"e0272807","DOI":"10.1371\/journal.pone.0272807","volume":"17","author":"E Allara","year":"2022","unstructured":"Allara E, Lee WH, Burgess S (2022) Genetically predicted cortisol levels and risk of venous thromboembolism. PLoS ONE 17(8):e0272807. https:\/\/doi.org\/10.1371\/journal.pone.0272807","journal-title":"PLoS ONE"},{"key":"1482_CR38","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae405","author":"WC Wu","year":"2024","unstructured":"Wu WC, Wu JL, Huang TS, Li CY, Li HY (2024) Cushing\u2019s syndrome is associated with a higher risk of cancer - a Nationwide cohort study. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgae405","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1482_CR39","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","volume":"34","author":"A Falanga","year":"2023","unstructured":"Falanga A, Ay C, Di Nisio M, Gerotziafas G, Jara-Palomares L, Langer F, Lecumberri R, Mandala M, Maraveyas A, Pabinger I, Sinn M, Syrigos K, Young A, Jordan K, Guidelines ESMO (2023) Venous thromboembolism in cancer patients: ESMO clinical practice guideline. Ann Oncol: Off J Eur Soc Med Oncol 34(5):452\u2013467. https:\/\/doi.org\/10.1016\/j.annonc.2022.12.014","journal-title":"Ann Oncol: Off J Eur Soc Med Oncol"},{"issue":"3","key":"1482_CR40","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1007\/s12020-018-1709-y","volume":"62","author":"D Hirsch","year":"2018","unstructured":"Hirsch D, Shimon I, Manisterski Y, Aviran-Barak N, Amitai O, Nadler V, Alboim S, Kopel V, Tsvetov G (2018) Cushing\u2019s syndrome: comparison between Cushing\u2019s disease and adrenal Cushing\u2019s. Endocrine 62(3):712\u2013720. https:\/\/doi.org\/10.1007\/s12020-018-1709-y","journal-title":"Endocrine"},{"issue":"5","key":"1482_CR41","doi-asserted-by":"publisher","first-page":"R207","DOI":"10.1530\/EJE-20-1309","volume":"184","author":"EV Varlamov","year":"2021","unstructured":"Varlamov EV, Langlois F, Vila G, Fleseriu M (2021) MANAGEMENT OF ENDOCRINE DISEASE: cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing\u2019s syndrome: a practical approach. Eur J Endocrinol 184(5):R207\u2013R224. https:\/\/doi.org\/10.1530\/EJE-20-1309","journal-title":"Eur J Endocrinol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01482-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-024-01482-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01482-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T14:32:53Z","timestamp":1741444373000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-024-01482-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1482"],"URL":"https:\/\/doi.org\/10.1007\/s11102-024-01482-0","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"5 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Michal Michaelis, Yaron Rudman, Idit Dotan, Tzipora Shochat, and Shiri Kushnir do not have any financial or personal relationships with other people or organizations to disclose. Ilan Shimon has been an investigator for Xeris Biopharma and has received occasional scientific fee for scientific consulting and advisory boards from Medison, CTS pharma, and Neopharm. Maria Fleseriu has been a PI with research funding to university from Crinetics, and Sparrow and has received occasional scientific fee for scientific consulting and advisory boards from Crinetics, Recordati, Sparrow and Xeris. Amit Akirov has received occasional scientific fee for scientific consulting and advisory boards from Medison, CTS pharma, and Neopharm. All authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}